This is likely because SIH in ACS, compared to known diabetes, represents an epiphenomenon of other pathological conditions, such as adrenergic and renin-angiotensin system overactivity, hyperglucagonaemia, increase of circulating FFAs and pancreatic beta-cell dysfunction, that are not completely reversed by insulin therapy and so worsen the prognosis. Here, REN is linked to diabetes mellitus.